Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer

NCT06980545 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Stage III and IV Ovarian Cancer

Interventions

DRUG: Neoadjuvant chemotherapy (Paclitaxel and Carboplatin)

Sponsor

Assiut University